Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
Treatment with lucinactant, a peptide-containing synthetic lung surfactant, will be evaluated
in young children with acute respiratory failure who require mechanical ventilation (life
support), to determine if it is safe and if treatment with lucinactant will reduce the number
of days a child needs mechanical ventilation (life support).